A citation-based method for searching scientific literature

J M Fearnley, A J Lees. Brain 1991
Times Cited: 2177







List of co-cited articles
712 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Staging of brain pathology related to sporadic Parkinson's disease.
Heiko Braak, Kelly Del Tredici, Udo Rüb, Rob A I de Vos, Ernst N H Jansen Steur, Eva Braak. Neurobiol Aging 2003
18

MDS clinical diagnostic criteria for Parkinson's disease.
Ronald B Postuma, Daniela Berg, Matthew Stern, Werner Poewe, C Warren Olanow, Wolfgang Oertel, José Obeso, Kenneth Marek, Irene Litvan, Anthony E Lang,[...]. Mov Disord 2015
16


Disease duration and the integrity of the nigrostriatal system in Parkinson's disease.
Jeffrey H Kordower, C Warren Olanow, Hemraj B Dodiya, Yaping Chu, Thomas G Beach, Charles H Adler, Glenda M Halliday, Raymond T Bartus. Brain 2013
547
14

Parkinson's disease.
Lorraine V Kalia, Anthony E Lang. Lancet 2015
12

Alpha-synuclein in Lewy bodies.
M G Spillantini, M L Schmidt, V M Lee, J Q Trojanowski, R Jakes, M Goedert. Nature 1997
11

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
A J Hughes, S E Daniel, L Kilford, A J Lees. J Neurol Neurosurg Psychiatry 1992
10

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.
M H Polymeropoulos, C Lavedan, E Leroy, S E Ide, A Dehejia, A Dutra, B Pike, H Root, J Rubenstein, R Boyer,[...]. Science 1997
9

Parkinson disease.
Werner Poewe, Klaus Seppi, Caroline M Tanner, Glenda M Halliday, Patrik Brundin, Jens Volkmann, Anette-Eleonore Schrag, Anthony E Lang. Nat Rev Dis Primers 2017
9

Parkinson's disease: mechanisms and models.
William Dauer, Serge Przedborski. Neuron 2003
9


Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain.
Clifford M Cassidy, Fabio A Zucca, Ragy R Girgis, Seth C Baker, Jodi J Weinstein, Madeleine E Sharp, Chiara Bellei, Alice Valmadre, Nora Vanegas, Lawrence S Kegeles,[...]. Proc Natl Acad Sci U S A 2019
39
17

Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria.
Dennis W Dickson, Heiko Braak, John E Duda, Charles Duyckaerts, Thomas Gasser, Glenda M Halliday, John Hardy, James B Leverenz, Kelly Del Tredici, Zbigniew K Wszolek,[...]. Lancet Neurol 2009
470
7

Seven-Tesla magnetic resonance images of the substantia nigra in Parkinson disease.
Dae-Hyuk Kwon, Jong-Min Kim, Se-Hong Oh, Hye-Jin Jeong, Sung-Yeon Park, Eung-Seok Oh, Je-Geun Chi, Young-Bo Kim, Beom S Jeon, Zang-Hee Cho. Ann Neurol 2012
122
7


Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.
Raúl de la Fuente-Fernández, Michael Schulzer, Lisa Kuramoto, Jacquelyn Cragg, Nandhagopal Ramachandiran, Wing L Au, Edwin Mak, Jess McKenzie, Siobhan McCormick, Vesna Sossi,[...]. Ann Neurol 2011
150
7

MDS research criteria for prodromal Parkinson's disease.
Daniela Berg, Ronald B Postuma, Charles H Adler, Bastiaan R Bloem, Piu Chan, Bruno Dubois, Thomas Gasser, Christopher G Goetz, Glenda Halliday, Lawrence Joseph,[...]. Mov Disord 2015
534
6

Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI.
Anna I Blazejewska, Stefan T Schwarz, Alain Pitiot, Mary C Stephenson, James Lowe, Nin Bajaj, Richard W Bowtell, Dorothee P Auer, Penny A Gowland. Neurology 2013
155
6

Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease.
Ioannis U Isaias, Paula Trujillo, Paul Summers, Giorgio Marotta, Luca Mainardi, Gianni Pezzoli, Luigi Zecca, Antonella Costa. Front Aging Neurosci 2016
75
8

In Vivo Assessment of Brainstem Depigmentation in Parkinson Disease: Potential as a Severity Marker for Multicenter Studies.
Stefan T Schwarz, Yue Xing, Pragya Tomar, Nin Bajaj, Dorothee P Auer. Radiology 2017
39
15

T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease.
Stefan T Schwarz, Timothy Rittman, Vamsi Gontu, Paul S Morgan, Nin Bajaj, Dorothee P Auer. Mov Disord 2011
97
6

Clinical progression in Parkinson disease and the neurobiology of axons.
Hsiao-Chun Cheng, Christina M Ulane, Robert E Burke. Ann Neurol 2010
423
6

Epidemiology of Parkinson's disease.
Ole-Bjørn Tysnes, Anette Storstein. J Neural Transm (Vienna) 2017
509
6

Diagnostic criteria for Parkinson disease.
D J Gelb, E Oliver, S Gilman. Arch Neurol 1999
5

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.
Daniel G Healy, Mario Falchi, Sean S O'Sullivan, Vincenzo Bonifati, Alexandra Durr, Susan Bressman, Alexis Brice, Jan Aasly, Cyrus P Zabetian, Stefano Goldwurm,[...]. Lancet Neurol 2008
895
5

The role of iron in brain ageing and neurodegenerative disorders.
Roberta J Ward, Fabio A Zucca, Jeff H Duyn, Robert R Crichton, Luigi Zecca. Lancet Neurol 2014
585
5

A longitudinal study of neuromelanin-sensitive magnetic resonance imaging in Parkinson's disease.
Keita Matsuura, Masayuki Maeda, Ken-Ichi Tabei, Maki Umino, Hiroyuki Kajikawa, Masayuki Satoh, Hirotaka Kida, Hidekazu Tomimoto. Neurosci Lett 2016
30
16

Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease.
David Sulzer, Clifford Cassidy, Guillermo Horga, Un Jung Kang, Stanley Fahn, Luigi Casella, Gianni Pezzoli, Jason Langley, Xiaoping P Hu, Fabio A Zucca,[...]. NPJ Parkinsons Dis 2018
70
7

Midbrain iron content in early Parkinson disease: a potential biomarker of disease status.
W R Wayne Martin, Marguerite Wieler, Myrlene Gee. Neurology 2008
259
5

Relationship between neuromelanin and dopamine terminals within the Parkinson's nigrostriatal system.
Antonio Martín-Bastida, Nicholas P Lao-Kaim, Andreas Antonios Roussakis, Graham E Searle, Yue Xing, Roger N Gunn, Stefan T Schwarz, Roger A Barker, Dorothee P Auer, Paola Piccini. Brain 2019
16
31

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.
J W Langston, P Ballard, J W Tetrud, I Irwin. Science 1983
5

Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.
John P Anderson, Donald E Walker, Jason M Goldstein, Rian de Laat, Kelly Banducci, Russell J Caccavello, Robin Barbour, Jiping Huang, Kristin Kling, Michael Lee,[...]. J Biol Chem 2006
730
5

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
Christopher G Goetz, Barbara C Tilley, Stephanie R Shaftman, Glenn T Stebbins, Stanley Fahn, Pablo Martinez-Martin, Werner Poewe, Cristina Sampaio, Matthew B Stern, Richard Dodel,[...]. Mov Disord 2008
5


Magnetic resonance correlation of iron content with neuromelanin in the substantia nigra of early-stage Parkinson's disease.
S Reimão, S Ferreira, R G Nunes, P Pita Lobo, D Neutel, D Abreu, N Gonçalves, J Campos, J J Ferreira. Eur J Neurol 2016
31
16


Parkin is recruited selectively to impaired mitochondria and promotes their autophagy.
Derek Narendra, Atsushi Tanaka, Der-Fen Suen, Richard J Youle. J Cell Biol 2008
5

Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies.
Mike A Nalls, Cornelis Blauwendraat, Costanza L Vallerga, Karl Heilbron, Sara Bandres-Ciga, Diana Chang, Manuela Tan, Demis A Kia, Alastair J Noyce, Angli Xue,[...]. Lancet Neurol 2019
294
4

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.
T Kitada, S Asakawa, N Hattori, H Matsumine, Y Yamamura, S Minoshima, M Yokochi, Y Mizuno, N Shimizu. Nature 1998
4

Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism.
Vincenzo Bonifati, Patrizia Rizzu, Marijke J van Baren, Onno Schaap, Guido J Breedveld, Elmar Krieger, Marieke C J Dekker, Ferdinando Squitieri, Pablo Ibanez, Marijke Joosse,[...]. Science 2003
4

The epidemiology of Parkinson's disease: risk factors and prevention.
Alberto Ascherio, Michael A Schwarzschild. Lancet Neurol 2016
506
4


Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis.
Giovanni Rizzo, Massimiliano Copetti, Simona Arcuti, Davide Martino, Andrea Fontana, Giancarlo Logroscino. Neurology 2016
224
4


Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approach.
Xiangchuan Chen, Daniel E Huddleston, Jason Langley, Sinyeob Ahn, Christopher J Barnum, Stewart A Factor, Allan I Levey, Xiaoping Hu. Magn Reson Imaging 2014
52
7

Free-water imaging in Parkinson's disease and atypical parkinsonism.
Peggy J Planetta, Edward Ofori, Ofer Pasternak, Roxana G Burciu, Priyank Shukla, Jesse C DeSimone, Michael S Okun, Nikolaus R McFarland, David E Vaillancourt. Brain 2016
96
4

Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review.
Klaus Seppi, K Ray Chaudhuri, Miguel Coelho, Susan H Fox, Regina Katzenschlager, Santiago Perez Lloret, Daniel Weintraub, Cristina Sampaio. Mov Disord 2019
199
4



Parkinson's disease.
Andrew J Lees, John Hardy, Tamas Revesz. Lancet 2009
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.